Phytotherapeutic Potential and Pharmacological Dynamics of Catharanthus pusillus in Metabolic Disorders
Metabolic disorders, particularly Diabetes Mellitus (DM) and associated secondary hyperlipidemia, pose a critical global public health burden. Medicinal plants have historically served as indispensable reservoirs for therapeutic discovery, offering complex bioactive secondary metabolites with multi-target mechanisms. Catharanthus pusillus (Murray) G. Don (Family: Apocynaceae), commonly known as "Tiny Periwinkle," is an ethnobotanically significant annual herb indigenous to India and Sri Lanka. Though closely related to the pharmacologically celebrated Catharanthus roseus, C. pusillus remains under-explored despite its rich repository of bioactive alkaloids, flavonoids, phenolic compounds, and terpenoids. This comprehensive review synthesizes current knowledge on the botanical features, phytoconstituent profiles, traditional applications, and mechanisms of action of C. pusillus. Particular focus is given to its dual therapeutic roles in modulating glycemic control via pancreatic -cell restoration and -amylase inhibition, as well as mitigating dyslipidemia by targeting atherogenic lipid fractions.
Authors
- Komal Nowal*1, Richa Agarwal2, Rajesh Asija3
Publication Details
- Journal
- International Journal of Medical & Pharmaceutical Sciences
- Published
- 2026-11-21
- DOI
- https://doi.org/10.5281/zenodo.24413909
- Primary Topic
- Natural Antidiabetic Agents Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00